Inappropriate implantable defibrillator shocks: an adverse outcome that can be prevented

J Am Coll Cardiol. 2013 Oct 8;62(15):1351-2. doi: 10.1016/j.jacc.2013.05.055. Epub 2013 Jun 13.

Author

Merritt H Raitt¹

Affiliation

¹ Division of Cardiology, Portland Veterans' Affairs Medical Center and Knight Cardiovascular Institute, Oregon Health & Science University, Portland, Oregon. Electronic address: merritt.raitt@va.gov.

PMID: 23770170
DOI: 10.1016/j.jacc.2013.05.055

No abstract available

Keywords: beta-blockers; carvedilol; defibrillator; heart failure; inappropriate therapy.

Publication types

Editorial
Comment

MeSH terms

Carbazoles / therapeutic use*
Cardiac Resynchronization Therapy*
Carvedilol
Defibrillators, Implantable*
Female
Heart Failure / therapy*
Humans
Male
Metoprolol / therapeutic use*
Propanolamines / therapeutic use*

Substances

Carbazoles
Propanolamines
Carvedilol
Metoprolol